AustinPx Pharmaceutics and Manufacturing

About

Our customers face significant challenges in drug development, particularly with poor bioavailability and accelerated timelines, which is why we have dedicated ourselves to providing science-driven solutions that bridge the gap between discovery and patient care. As a contract development and manufacturing organization (CDMO), AustinPx specializes in enhancing the bioavailability of poorly soluble molecules, ensuring that promising drug candidates can successfully reach the clinic and the market. We empower our clients by offering a comprehensive suite of services, from preclinical formulation and process development to GMP manufacturing of oral dosage forms. Our proprietary KinetiSol™ Technology represents a next-generation approach to amorphous solid dispersions, offering a greener, more efficient, and scalable alternative to traditional methods. By adopting a data-driven and agnostic approach, we tailor our strategies to the unique physiochemical properties of each molecule, helping our partners overcome complex formulation hurdles and deliver life-saving therapies to patients faster.